Clinical trial
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the…
NCT00204594 · University Hospital Tuebingen, Other · Completed
Key facts
| NCT number | NCT00204594 |
|---|---|
| Title | Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 |
| Official title | Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28 |
| Lead sponsor | University Hospital Tuebingen, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Melanoma |
| Intervention type | Drug |
| Interventions | rM28, autologous PBMCs |
| Enrollment | 1 |
| Start date | Oct 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 16, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: